Jeffrey B. Landau SEC EDGAR Filings (CIK 0001918615)

SEC EDGAR filings, ownership reports, and insider transactions for Jeffrey B. Landau.

Business address
C/O Cytomx Therapeutics, Inc., 151 Oyster Point Blvd., Suite 400, South San Francisco, CA, 94080
Top holdings (ownership)
CTMX
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Jeffrey B. Landau has filed 11 SEC EDGAR filings since 28 Mar 2022

Latest Filings

Recent SEC filings for Jeffrey B. Landau including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 22 Aug 2024 20 Aug 2024 001-37587
4 Open 4 document View SEC filing for 4 21 Mar 2024 19 Mar 2024 001-37587
4 Open 4 document View SEC filing for 4 19 Jan 2024 18 Jan 2024 001-37587
4 Open 4 document View SEC filing for 4 22 Dec 2023 20 Dec 2023 001-37587
4 Open 4 document View SEC filing for 4 19 Dec 2023 17 Dec 2023 001-37587
4 Open 4 document View SEC filing for 4 22 Sep 2023 20 Sep 2023 001-37587
4 Open 4 document View SEC filing for 4 20 Mar 2023 16 Mar 2023 001-37587
4 Open 4 document View SEC filing for 4 FORM 4 06 Feb 2023 02 Feb 2023 001-37587
4 Open 4 document View SEC filing for 4 FORM 4 12 Aug 2022 10 Aug 2022 001-37587
4 Open 4 document View SEC filing for 4 FORM 4 21 Jul 2022 19 Jul 2022 001-37587
3 Open 3 document View SEC filing for 3 FORM 3 28 Mar 2022 23 Mar 2022 001-37587

About this filer

Jeffrey B. Landau files with the SEC under CIK 0001918615. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages